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Y-DELETIONS IN MEN WITH SEVERE OLIGOSPERMIA.
Eric J. Meuleman, Jan A. Kremer, Joep H. Tuerlings, Nijmegen, The 
Netherlands. (Presented bij Dr. Meuleman)
The introduction of ICSI offered a successful treatment option for 
subfertile male with severe oligospermia, although the etiology of the 
disorder remains unclear in most cases. Recently, micro-deletions in the 
AZF region of the Y chromosome have been detected in men with 
azoospermia or severe oligospermia.
In this study we investigated the prevalence of microdeletions in the 
AZFc region of the Y chromosome in our ICSI population (by PCR analysis) 
and looked for clinical differences between the men and without the 
deletion. Blood was drawn from 154 men, who were waiting for ICSI 
treatment: 24 azoospermie men, 98 oligospermie and 32 normospermie 
men. (after previous fertilization failure). Chromosome analysis showed 4 
Klinefelters in the azoospermie group and two Klinefelters in the 
oligospermie group. One translocation was observed in the oligospermie 
group. Microdeletions in the AZFc region were present in 7 of the 98 
oligospermie men (7%). None of these 7 men had abnormal findings on 
andrologie history and examination. No microdeletions were found in the 
azoospermie and normospermie group.
We conclude that microdeletions in the AZFc region of the Y- 
chromosome are frequently found in men with severe oligospermia and 
with no other causal factors. We recommend DNA screening (and genetic 
counseling) in this population of subfertile men.
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THE EFFECTS OF PERCOLL ON THE OPTIMIZED SPERM 
PENETRATION ASSAY (SPA)
Steven Lewitton, Benjamin M. Tripp, Marina Gvakharia, Larry I. Lipshultz, Dolores 
J. Lamb. Houston, Tx (Presented by Dr. Tripp)
INTRODUCTION: The SPA is an important sperm function test that reveals 
information about sperm capacitation, acrosome reaction, membrane fusion and 
chromatin decondensation. At our institution, the SPA has been highly correlated with 
successful outcome in IVF (Johnson et al, Fertil Steril 56:528,1991). Percoll has been 
used extensively in sperm processing for IUI (intrauterine insemination), IVF and 
ICSI (intracytoplasmic sperm injection). The objective of this study was to determine 
the effect of Percoll processing on sperm penetrating ability.
METHODS: This is a retrospective study of 125 patients out o f 1200 men who 
underwent the optimized SPA both before and after Percoll processing from January 
1993 to July 1996. 97% of patients had more than 40 million motile spermatozoa on 
semen analysis. The SPA result is scored by the SCI (sperm capacitation index); the 
SCI > 5 is normal, SCI < 5 moderately abnormal,and SCI <4 is severely abnormal.
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RESULTS: SPA RESULTS AFTER PERCOLL PROCESSING
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SPA SCORE
Patients
(Before
Percoll)
Improved
Score
After Percoll
Decreased
Scorc
After Percoll
Abnormal SPA converted 
to normal SPA 
After Percoll
. .  . . . .  r .  
Normal 68 59 (92%) 5 (10%) «ft
Moderately
Abnormal
57 40 (85%) 5 (8%) 39 (70%)
Severely
Abnormal
14 2 (14%) 6 (43%) 2 (14%)
Total 125 99 (89%) 10 (9%)
The only group of patients that did not have their SPA significantly improved by 
Percoll processing was the group with a severely abnormal SPA (17% of the infertile 
males (199/1200) tested by the SPA), (Chi Squared Test, P > 0,05).
CONCLUSIONS: Percoll processing was found to improve the SPA score in 89% 
of patients. Patients with mild to moderate penetration dysfunction as assessed by the 
SPA can potentially be treated with Percoll processing of their semen in conjunction 
with IUI, IVF and ICSI. However, patients with severe sperm penetrating 
abnormalities were not significantly helped by Percoll processing, suggesting that this 
group can only be successfully treated with ICSI,
(Supported in part by the Kidney Foundation of Canada)
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EVALUATION OF CANDIDATE AZOOSPERMIA GENES CREM, 
hHR6B, PMS1, AND SMCY IN CASES OF NON OBSTRUCTED 
AZOOSPERMIA John T. B. Houston, Alexander I. Agoulnik, Larry I. 
Lipshultz, Dolores J. Lamb, Colin E. Bishop, Houston, TX (Presented by 
Dr. Houston).
INTRODUCTION AND OBJECTIVES: The increasing use of ICSI 
(Intracytoplasmic Sperm Injection) for cases of testicular failure 
underscores the importance of identifying genes involved in 
spermatogenesis. Evidence to date suggests that deletions within Y 
chromosome long ami interval 6 are associated with diffuse defects in 
spermatogenesis. A candidate gene distal to this region, DAZ (Deleted in 
Azoospermia), has been identified with deletions in only 11-18% of 
azoospermic patients. The possibility of deletions or aberrations in other 
genes controlling spermatogenesis exists. Recent studies involving gene 
knockouts experiments o f  CREM (Cyclic AMP-responsive Element 
Modulator) and hHR6B (human homologue ubiquitin-conjugating yeast 
enzyme) in mice have demonstrated a variety of defects in 
spermatogenesis rendering mice either azoospermic or severely 
oligospermic. Mutant mice deleted for a region on the Y chromosome 
including SMCY ( a Y specific chromosomal gene) exhibit failure of 
spermatogenesis. It has also been observed in Yeast that deficiency of 
PMSl(a DNA mismatch repair system ) results in meiotic sterility. The role 
o f  these genes in human spermatogenesis is unknown. We report the 
screening o f DNA from 50 azoospermic/oligospermic males for candidate 
genes CREM, hHR6B, PMS1, and SMCY.
METHODS: DNA was obtained from 56 men presenting with 
idiopathic infertility. cDNA s to candidate genes CREM, hHR6B, PMS1, 
and SMCY were obtained and a molecular probe to each created. Using 
Southern Blot analysis, genomic DNA from each patient was then probed 
for each o f the above candidate genes.
RESULTS; CREM, SMCY, PMS1 and hHR6B genes were identified in 
all 50 patients. Under stringent conditions, Southern Blot analysis did not 
detect any large deletions resulting in differential banding patterns in any 
o f  the 34 azoospermic or 16 oligospermic patients compared to normal 
controls.
CONCLUSIONS: Although large deletions were not observed, these 
data do not exclude the possibility that the above candidate genes may play 
a significant role in human male spermatogenesis. Tlie [possibility exists 
¿nat microdeletions/mutations may contribute to gene impairment 
resulting in the observed phenotypes.
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EFFECT OF SODIUM NITROPRUSSIDE ON SPERM  
MOTILITY: A DOSE-RESPONSE CURVE. Francis G Martinis, 
Nassim Viiji, Harris M Nagler, New York, NY. (Presented by Dr. 
Martinis).
Objective: Nitric Oxide (NO) has been shown to improve the 
maintenance o f sperm motility in cryopressrved human sperm, as well as 
increase the yield of motile sperm using swim-up methods. However, an 
inhibition o f sperm motility by NO at higher concentrations has also 
been reported. This suggests that NO may exert its effect on motility in 
a dose dependent manner. To investigate this hypothesis, we generated 
dose-response curves to evaluate the effects o f NO on sperm motility 
over a wide range of concentrations using sodium nitroprusside as the 
NO donor.
Methods: Motile sperm obtained from two known fertile donors (two 
specimens each) and three infertile patients were separated on a Percoll 
gradient. Sodium nitroprusside was added in decreasing concentrations 
to the washed semen aliquots, to achieve final concentrations in the tube 
of lxlO'2 to lx l0 ’8 M. Sperm concentration in each tube was 20 
million/ml. A control tube was maintained without sodium 
nitroprusside. Sperm motility was evaluated after two hours incubation 
at 37° C.
Results: Sperm motility in the control ranged from 71% to 84%. 
High concentrations of sodium nitroprusside (lxlO'2 M and lxlO*3 M) 
were inhibitory to sperm motility resulting in final motility o f 1% to 
39%. At the concentration o f lxlO“4 M, sperm motility returned to 
baseline value (i.e. control motility). Between 1x10“* M and lxlO'8 M 
sodium nitroprusside, there was a trend towards enhanced motility 
(range: 71% to 95%).
Conclusions: The dose-response curves for both donors and patients 
were indentical, that is, inhibition at higher concentrations o f sodium 
nitroprusside ( lx l0 ‘2 M and 1x10° M) and no inhibition or mild 
enhancement of sperm motility at lower concentrations of sodium 
nitroprusside (1x10^ M and lx l0 ‘*M).
